LivaNova makes medical devices for heart and lung surgery and neuromodulation, including a system for treating sleep apnea. It last closed at $91.92 on Nov 17, down 0.56% on the day. The average 12-month price target from 4 analysts is $108.25 (+17.8% from the last close), with a high of $120.00 and a low of $90.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell).
Each firm's latest rating on LIVN in the past 90 days
Average 12-month target
$108.25
▲ 17.8% upside
Based on 4 analysts who set a price target on LIVN in the past 90 days. The average target is $108.25, with a high of $120.00 and a low of $90.00, compared with the last close of $91.92.
Low $90.00Avg $108.25High $120.00
Blue marker: last close $91.92
Highest target$120.00
Average target$108.25
Lowest target$90.00
Latest rating changes
BarclaysTarget raised
Nov 9Buy$105 → $120
BairdMaintained
Nov 5Buy$111
NeedhamTarget raised
Nov 4Buy$93 → $112
BarclaysInitiated
Oct 7Buy$105
Piper SandlerReiterated
Sep 2Buy$90
Date
Firm
Action
Rating
Price target
Nov 9
Barclays
Target raised
Buy
$105 → $120
Nov 5
Baird
Maintained
Buy
$111
Nov 4
Needham
Target raised
Buy
$93 → $112
Oct 7
Barclays
Initiated
Buy
$105
Sep 2
Piper Sandler
Reiterated
Buy
$90
Loading…
Technical Analysis
LIVN · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 7% above its 20 day and 12% above its 50 day average. It is 19% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $91.15, and the nearest resistance the Pivot at $92.40.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 3.5%/day
Key levels
$99.3852 week high+8.1%
$99.38Swing high (Nov 4)+8.1%
$93.16Pivot R1+1.3%
$92.40Pivot+0.5%
$91.92Last close
$91.15Pivot S1−0.8%
$85.9320 day average−6.5%
$80.7650 day average−12.1%
$80.69100 day average−12.2%
$78.41Swing low (Oct 30)−14.7%
$74.44200 day average−19.0%
$52.3752 week low−43.0%
Indicators
RSI (14)
65.56
Strong, overbought above 70
Neutral
MACD
3.60
Above its signal line
Bullish
Stochastic
64.3
Middle of its range
Neutral
ADX (14)
31.6
Trending up
Williams %R
-35.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
75.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+15.0%
Change over 10 sessions
Bullish
ATR (14)
$3.23
Typical daily range, 3.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 6.4%/day
Key levels
$99.3852 week high+8.1%
$99.38Swing high (Nov 4)+8.1%
$93.16Pivot R1+1.3%
$92.40Pivot+0.5%
$91.92Last close
$91.15Pivot S1−0.8%
$85.9320 day average−6.5%
$80.7650 day average−12.1%
$80.69100 day average−12.2%
$78.41Swing low (Oct 30)−14.7%
$74.44200 day average−19.0%
$52.3752 week low−43.0%
Indicators
RSI (14)
68.39
Strong, overbought above 70
Neutral
MACD
4.10
Above its signal line
Bullish
Stochastic
67.1
Middle of its range
Neutral
ADX (14)
29.3
Trending up
Williams %R
-29.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
238.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+17.6%
Change over 10 sessions
Bullish
ATR (14)
$5.84
Typical daily range, 6.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for LIVN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LIVN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow LIVN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LIVN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LIVN is in one of them and how their past LIVN trades turned out.
LivaNova is a medical device company based in Gloucester, UK. Its Cardiopulmonary business sells perfusion systems and related consumables used in surgery involving the heart and lungs. Its Neuromodulation business offers devices, including a system in development for treating sleep apnea. The company sells its products in the United States, Europe and other regions around the world.